News for 'science-and-engineering-research-board'

Will Monsoon Session Be Another Washout?

Will Monsoon Session Be Another Washout?

Rediff.com27 Jul 2023

The productivity of the Budget session was abysmal. The Lok Sabha functioned for 33% of its scheduled time (46 hours); the Rajya Sabha 24% (32 hours).

Bill on uniform civil code not listed for monsoon session of Parliament

Bill on uniform civil code not listed for monsoon session of Parliament

Rediff.com13 Jul 2023

The government on Thursday listed bills on personal data protection, to amend forest conservation laws and on the contentious ordinance on Delhi services for the monsoon session of Parliament beginning next week.

Kashmiri researcher leaves BITS Pilani campus after threats

Kashmiri researcher leaves BITS Pilani campus after threats

Rediff.com24 Apr 2017

Hashim Sofi, who hails from Bandipora district of Kashmir, had told the hostel's chief warden that on Friday morning, he had found the door of his room and his clothes inked with threats and abuses, an official of the institute said.

COVID-19 cases in India to peak between June 21-28: Study

COVID-19 cases in India to peak between June 21-28: Study

Rediff.com22 May 2020

The study has predicted that confirmed COVID-19 cases reported daily will show a rising graph till the end of June. "A clear downward trend in the confirmed cases is likely to be observed each day from the second week of July," Nandadulal Bairagi, a senior professor of Jadavpur University who was involved in the project told PTI.

COVID vaccine likely to be available by first of 2021: Choubey

COVID vaccine likely to be available by first of 2021: Choubey

Rediff.com19 Sep 2020

Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Rediff.com15 Sep 2020

Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, minister of state for health Ashwini Choubey informed the Rajya Sabha on Tuesday.